Neuroendocrine Tumor G1 — Trials

Neuroendocrine Tumor G1 — Trials · CancerIndex

Clinical trials

Registered studies

65 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03375320	Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors	active not recruiting	Phase 3	298	National Cancer Institute (NCI)NIH	1	Sep 22, 2026	clinicaltrials
NCT00569127	Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor	active not recruiting	Phase 3	427	National Cancer Institute (NCI)NIH	1	Aug 28, 2026